Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
01.02.2017 22:48:00

mHealth Wearables Boost Patient Healthcare Both Inside and Outside the Hospital


ABI Research Forecasts Patient Monitoring Wearable Shipments to Grow by 32% by 2021

LONDON, Feb. 1, 2017 /PRNewswire/ -- A surge in healthcare patient monitoring wearables will soon help reduce readmission risks and better prevent the occurrence of serious medical traumas, alleviating growing performance pressures on healthcare services. ABI Research forecasts the patient monitoring wearable market, which includes remote and on-site devices, will grow from 8 million shipments in 2016 to 33 million in 2021. Device types are diverse and include staples like blood pressure monitors, continuous glucose monitors, and pulse oximeters, as well as newer devices like Fatigue Science's fatigue monitoring wearable.

"While previously professional-grade patient monitoring largely limited itself to a doctor's rounds, new wearables allow medical professionals to remotely and continuously monitor patients in the hospital and beyond," says Stephanie Lawrence, Research Analyst at ABI Research. "The devices send real-time alerts regarding any condition deteriorations or fluctuations, in effect reducing response times to potentially life-threatening changes and saving the healthcare system resources in the long term."

On-site professional healthcare monitoring wearables, such as those by Philips Healthcare, allow medical professionals to work with a larger base of patients, as the devices continuously update doctors throughout the day on patients' vitals and overall conditions without the need for physical check-ins. The wearables also, in effect, help to ensure that doctors do not overlook any slight changes in condition before granting patients release.

Beyond the hospital, remote patient monitoring wearables, such as blood pressure monitors and telemedicine products by A&D Medical, then provide healthcare professionals with continued access to their patients' health, which would have otherwise been inaccessible once they left the confines of the hospital. As such, doctors can now, like with on-site treatment, monitor their patients' conditions and better diagnose any treatment adjustments that may be necessary on the path to recovery.

A&D Medical, Medtronic, Nonin Medical, and Philips Healthcare lead the market, with startups like Fatigue Science, Health Care Originals, and Qardio beginning to challenge the incumbents and diversify the competitive landscape in offering solutions to treat specific medical conditions.

"Remote patient monitoring devices will see strong growth of nearly 35% by 2021, and will take up a 60% share of the patient monitoring market as healthcare professionals embrace the benefits that come with the ability to remotely and continuously monitor patients' vitals," concludes Lawrence.

These findings are part of ABI Research's Patient Monitoring Wearables in Healthcare (https://www.abiresearch.com/market-research/product/1025761-patient-monitoring-wearables-in-healthcare/) report.

About ABI Research

ABI Research stands at the forefront of technology market research, providing business leaders with comprehensive research and consulting services to help them implement informed, transformative technology decisions. Founded more than 25 years ago, the company's global team of senior and long-tenured analysts delivers deep market data forecasts, analyses, and teardown services. ABI Research is an industry pioneer, proactively uncovering ground-breaking business cycles and publishing research 18 to 36 months in advance of other organizations. For more information, visit www.abiresearch.com.



Contact Info: Mackenzie Gavel 

Tel: +44.203.326.0142


pr@abiresearch.com

Logo - http://mma.prnewswire.com/media/276887/abi_research_logo.jpg

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!